These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 651452)

  • 1. [Preventive therapy in patients with recurrent kidney calculi].
    Backman U; Danielson BG; Johansson G; Ljunghall S
    Lakartidningen; 1978 May; 75(19):1917-8. PubMed ID: 651452
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium metabolism disorders in kidney calculi patients].
    Berlin T; Collste L; von Garrelts B
    Lakartidningen; 1978 May; 75(19):1911-2. PubMed ID: 651449
    [No Abstract]   [Full Text] [Related]  

  • 4. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do thiazides prevent recurrent renal calculi? Preliminary results of a double-blind controlled study].
    Brocks P; Dahl C; Transbøl I; Wolf H
    Ugeskr Laeger; 1982 Jun; 144(23):1669-70. PubMed ID: 6753287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Active and recurrent kidney calculi. Metabolic findings and therapeutic consequences].
    Jorgensen H; Quist Paulsen A; Berstad A; Harbitz TB
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1551-5. PubMed ID: 929531
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC
    Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of the recurrence of urinary lithiasis: mineral waters with high or low calcium content?].
    Sommariva M; Rigatti P; Viola MR
    Minerva Med; 1987 Dec; 78(24):1823-9. PubMed ID: 3431728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
    Jorgensen FS; Brünner S
    Scand J Urol Nephrol; 1974; 8(2):128-31. PubMed ID: 4838924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preventive medical treatment of recurrent urinary calcium calculi].
    François B; Trolliet P; Cahen R; Semet MP
    Nephrologie; 1986; 7(1):9-12. PubMed ID: 3960261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Treatment of renal stones: cellulose phosphate or magnesium?
    Cook DA
    N Engl J Med; 1974 Nov; 291(19):1034-5. PubMed ID: 4414452
    [No Abstract]   [Full Text] [Related]  

  • 12. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide.
    Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():125-34. PubMed ID: 6937988
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent renal calculi. Causes and prevention.
    Coe FL; Parks JH
    Hosp Pract (Off Ed); 1986 Mar; 21(3A):49-57. PubMed ID: 3081562
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-medicamentous prevention of calcium oxalate urinary calculi].
    Brundig P; Schulz E; Börner R; Haerting R; Janitzky V
    Z Urol Nephrol; 1989 Jun; 82(6):307-15. PubMed ID: 2763727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström
    Br J Urol; 1979 Jun; 51(3):175-80. PubMed ID: 465983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Preventive therapy for recurrent calcium nephrolithiasis-some recent trends.
    Chugh KS
    J Assoc Physicians India; 1974 Oct; 22(10):767-70. PubMed ID: 4448811
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary magnesium excretion in nephrolithiasis].
    Simeonov S; Dimitrakova D; Kumchev E
    Vutr Boles; 1988; 27(6):39-43. PubMed ID: 3247702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary excretion of calcium, magnesium and uric acid in kidney stone patients, their asymptomatic relatives and healthy subjects].
    González-Calvin JL; Montero García M; García Valdecasas J; Luna J; Raya Muñoz J; Peña Angulo JF; Peña Yáñez A
    Rev Clin Esp; 1981 Feb; 160(4):247-50. PubMed ID: 7268117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.